The Park Medi World IPO has turned into one of the most-watched issues this month, and for good reason. Every detail—from the Park Medi World IPO price band to the subscription timeline—has caught the attention of investors tracking upcoming hospital and healthcare listings.
There’s a sense of movement in the market this week, and this IPO has added to that momentum with its numbers, structure, and clear timelines.
Market Performance: A Busy Phase for Healthcare Offerings
The healthcare sector has been buzzing with activity, and the Park Medi World IPO has stepped right into the spotlight. The price band, dates, and lot size were announced in quick succession, pulling attention from both seasoned and first-time IPO watchers.
With the subscription window set for mid-December, the issue is already being discussed for its size, the structure of the offer, and the company’s hospital network spread across North India.
Main News: Park Medi World IPO Price Band & Subscription Schedule
The company has fixed the Park Medi World IPO price band at ₹154 to ₹162 per share.
This range ties back to the face value of ₹2 per equity share, with:
- Floor Price: 77x the face value
- Cap Price: 81x the face value
The Park Medi World IPO date for subscription opens on December 10 and closes on December 12.
A day before that—on December 9—the allocation to anchor investors will take place.
The public issue structure includes category-wise reservations:
- QIB: Not more than 50%
- NII: Not less than 15%
- Retail: Not less than 35%
The timeline that follows the close of the IPO is also clear:
- December 15: Finalisation of the basis of allotment
- December 16: Refunds and crediting of shares to demat accounts
- December 17: Park Medi World share price to list on BSE and NSE
Everything runs in a tight sequence, giving clarity to applicants, tracking allotment and listing updates.
Company Details & IPO Structure
The Park Medi World IPO has been structured as both a fresh issue and an Offer For Sale (OFS). The fresh issue component alone stands out because of its scale and specific utilisation plans.
Park Medi World IPO Breakdown
- Fresh Issue: ₹770 crore
- OFS: ₹150 crore
- IPO Price Band: ₹154–₹162 per share
- Lot Size: 92 equity shares and multiples thereafter
Use of Proceeds
The company has assigned the following utilisation plan for the fresh issue:
- ₹380 crore for debt repayment
- ₹60.5 crore will go toward setting up a new hospital and upgrading an existing facility.
- ₹27.45 crore for acquiring medical equipment across the company and its subsidiaries
- Remaining funds for acquisitions and general corporate purposes
Each number ties directly into the expansion and operational strengthening of its hospital network.
Business Overview: A Multi-Super Speciality Hospital Network
Park Medi World operates one of the well-known private hospital networks in North India. The company’s services and geographical spread play a key role in the scale of the IPO.
Its network includes:
- 14 multi-super speciality hospitals
- 3,000+ beds across all facilities (as of March 31, 2025)
- Locations are spread across Haryana, Delhi, Punjab, and Rajasthan.
All hospitals carry accreditation from NABH, while eight are also accredited by NABL, which adds credibility to diagnostic and testing capabilities.
The group operates under the ‘Park’ brand and covers over 30 super speciality and speciality services, including:
- Internal Medicine
- Neurology
- Urology
- Gastroenterology
- General Surgery
- Orthopaedics
- Oncology
The setup spans emergency care, advanced diagnostics, super speciality treatments, and surgical facilities, forming a complete healthcare ecosystem.
Summary
The Park Medi World IPO brings together a detailed structure, a clear price band of ₹154 to ₹162, and a subscription window from December 10 to 12. The offer includes both a fresh issue and an OFS, totalling significant capital meant for debt repayment, hospital development, expansion, and equipment upgrades.
With its 14-hospital network, 3,000-bed capacity, and extensive speciality services, the company enters the market with strong operational depth. The post-issue timeline—from allotment to listing—has been laid out clearly, giving applicants full visibility into the process ahead.
Easy & quick
Leave A Comment?